The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population

Peter Hobson
October 2010
Journal of Neurology, Neurosurgery & Psychiatry;Oct2010, Vol. 81 Issue 10, p1093
Academic Journal
OBJECTIVE: To compare survival, life expectancies (LE), and the anticipated age at the time of death (AAD), in a community-based cohort of Parkinson's disease (PD) patients with and without significant cognitive impairment, with an age sex matched population of England and Wales. METHODS: The age- and sex-specific standardised mortality ratios (SMR) were calculated and stratified by dementia status. The LE and AAD estimations were calculated from the SMRs of the 2003 UK population, using a modified Gompertz function. RESULTS: In total, 166 PD patients participated in the investigation, of which 91 died by the 4-year follow-up. The overall SMR was 2.09 (95% CI 1.68 to 2.57). Demented patients had significantly higher SMRs than non-demented patients (SMR 3.10, 95% CI 2.39 to 3.96 vs SMR 1.15, 95% CI 0.75 to 1.69, p75 years), the differences in LE (demented 2.1; SD 1 vs not demented 4.7; SD 4) and AAD were less apparent (demented 89.5; SD 6 vs not demented 92.2; SD 6). CONCLUSION: The survival, LE and AAD in patients with PD are much lower compared with the general population, apart from those patients who do not develop dementia, who appear to have near normal population mortalities. However, dementia and younger onset of PD appear to be important determinants of survival, LE and AAD.


Related Articles

  • Cognitive Decline as a Consequence of Essential Hypertension. Grassi, Davide; Ferri, Livia; Cheli, Paola; Di Giosia, Paolo; Ferri, Claudio // Current Pharmaceutical Design;9/21/2011, Vol. 17 Issue 28, p3032 

    Hypertension is a leading cardiovascular risk for cardiovascular morbidity and mortality. Age is the strongest risk factor for dementia and with the increasing life expectancy the number of patients living with dementia worldwide is estimated to progressively rise. A number of studies support an...

  • THE BARE ESSENTIALS. Kester, Maartje I.; Scheltens, Philip // Practical Neurology (BMJ Publishing Group);Aug2009, Vol. 9 Issue 4, p8 

    The article offers information on the syndrome dementia which is depicted by progressive deterioration of cognitive function, commonly of memory. According to the article, dementia is a difficulty that will increase as life expectancy increases. It is stated that dementia is also a growing...

  • Even mild cognitive impairment appears to substantially increase risk for death.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p179 

    The article reports on a study from the Regenstrief Institute for Health Care and the Indiana University School of Medicine which has identified that decreased life expectancy can be predicted through mild cognitive impairment.

  • Mortality in people taking selegiline: Observational study. Thorogood, Margaret; Armstrong, Ben; Nichols, Tom; Hollowell, Jen // BMJ: British Medical Journal (International Edition);07/25/98, Vol. 317 Issue 7153, p252 

    Cites a study which was conducted to examine and evaluate the mortality rate in patients with Parkinson's disease who take selegiline. Information on the Parkinson's disease Research Group trial of drug treatments for Parkinson's disease; Use of the General Practice Research Database; Details...

  • Untitled. Ryan, Patricia // Research Review (International Council on Active Aging);Jan2014, Vol. 14 Issue 2, p1 

    This section presents findings of studies on the U.S. active aging industry as of January 8, 2014. The Advanced Cognitive Training for Independent and Vital Energy (ACTIVE) study showed positive long-term effect of cognitive training on older adults. Participation in Tai Chai resulted to...

  • Investigation by Parkinson's Disease Research Group of... Ben-Shlomo, Y.; Churchyard, A.; Head, J.; Hurwitz, B.; Overstall, P.; Ockelford, J.; Lees, A.J. // BMJ: British Medical Journal (International Edition);04/18/98, Vol. 316 Issue 7139, p1191 

    Investigates the mortality in patients with Parkinson's disease who received both levodopa and selegiline in a randomized trial conducted by the Parkinson's Disease Research Group in Great Britain. Background on the study; Subjects and methods used; Findings; Conclusion.

  • The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial). Watne, Leiv Otto; Torbergsen, Anne Cathrine; Conroy, Simon; Engedal, Knut; Frihagen, Frede; Hjorthaug, Geir Aasmund; Juliebo, Vibeke; Raeder, Johan; Saltvedt, Ingvild; Skovlund, Eva; Wyller, Torgeir Bruun // BMC Medicine;2014, Vol. 12 Issue 1, p1 

    Background: Delirium is a common complication in patients with hip fractures and is associated with an increased risk of subsequent dementia. The aim of this trial was to evaluate the effect of a pre- and postoperative orthogeriatric service on the prevention of delirium and longer-term...

  • Noteworthy.  // Pharmaceutical Representative;Nov2007, Vol. 37 Issue 11, p15 

    The article offers news briefs in the U.S. and Great Britain in 2007. The "International Journal of Neuroscience" reported an association between frequent use of mobile phones and a decline in brain function. A study presented at the British Sleep Society found that those who cut their sleep...

  • Virtual Action Planning in Parkinson's Disease: AControl Study. Klinger, Evelyne; Chemin, Isabelle; Lebreton, Sophie; Marié, Rose-Marie // CyberPsychology & Behavior;Jun2006, Vol. 9 Issue 3, p342 

    Cognitive planning deficits affect patients with Parkinson's disease (PD) and traditional psychometric tests meet difficulties to evaluate their impact on daily life activities. Virtual reality (VR) may provide a new means of assessment. The objective of this study was firstly to develop a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics